Related Articles
Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy
Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer
Tie2/Tek expression in breast carcinoma: Correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients
Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma
Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients